Cargando…

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)

Detalles Bibliográficos
Autores principales:	B., ANDEMARIAM, J., JAMES, C., MINNITI, B., INUSA, F., EL RASSI, A., NERO, C., TRIMNELL, M., ABBOUD, J., ARLET, R., COLOMBATTI, M., DE MONTALEMBERT, S., JAIN, W., JASTANIAH, E., NUR, M., PITA, L., DEBONNETT, T., BAILEY, O., RAJKOVIC-HOOLEY, I., OSUNKWO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429758/ http://dx.doi.org/10.1097/01.HS9.0000872944.75352.79

Ejemplares similares

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Andemariam, B., et al.
Publicado: (2022)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2021)

Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2022)

Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings
por: Strunk, Crawford, et al.
Publicado: (2020)

Hemolysin Co-regulated Family Proteins Hcp1 and Hcp2 Contribute to Edwardsiella ictaluri Pathogenesis
por: Kalindamar, Safak, et al.
Publicado: (2021)

P1487: SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE ON PATIENTS AND THEIR UNMET NEEDS AS REPORTED BY HEALTHCARE PROFESSIONALS
por: de Montalembert, M., et al.
Publicado: (2022)

Higgs to tau tau (SM) (HCP)
por: CMS Collaboration
Publicado: (2012)

Higgs to tau tau (MSSM) (HCP)
por: CMS Collaboration
Publicado: (2012)

Hydrogen and helium trapping in hcp beryllium
por: Zimber, Nikolai, et al.
Publicado: (2023)

2009 CERN-Fermilab HCP Summer School
por: CERN. Geneva
Publicado: (2009)

P-004: HEALTH CARE TRANSITION (HCT) FOR SICKLE CELL DISEASE (SCD) CAN BE STANDARDIZED: RESULTS OF IMPLEMENTING A SCD HCT LEARNING COLLABORATIVE.
por: I., OSUNKWO, et al.
Publicado: (2022)

O-10: SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND UNMET NEEDS AS REPORTED BY PATIENTS AND CAREGIVERS
por: I., ODAME, et al.
Publicado: (2022)

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
por: Andemariam, B., et al.
Publicado: (2023)

Nucleation and growth mechanisms of hcp domains in compressed iron
por: Pang, Wei-Wei, et al.
Publicado: (2014)

Pressure effect on stabilities of self-Interstitials in HCP-Zirconium
por: Peng, Qing, et al.
Publicado: (2014)

S121: REDUCED RATE OF VASO-OCCLUSIVE CRISES (VOCS) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) TREATED WITH CRIZANLIZUMAB FOR 12 MONTHS: RESULTS FROM A REAL-WORLD, MANAGED ACCESS PROGRAM (MAP)
por: Silva-Pinto, A, et al.
Publicado: (2022)

5612992 SICKLE CELL HEALTH AWARENESS, PERSPECTIVES, AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS AND CAREGIVERS IN THE UK
por: Inusa, B.P.D., et al.
Publicado: (2023)

O-04: INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB IN A REAL-WORLD SETTING: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)
por: A., SILVA-PINTO, et al.
Publicado: (2022)

P1491: REAL-WORLD INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)
por: Silva-Pinto, A. C., et al.
Publicado: (2022)

Distributed Dynamic Host Configuration Protocol (D2HCP)
por: Villalba, Luis Javier García, et al.
Publicado: (2011)

First Principles Theory of the hcp-fcc Phase Transition in Cobalt
por: Lizárraga, Raquel, et al.
Publicado: (2017)

Roles of the Hcp family proteins in the pathogenicity of Salmonella typhimurium 14028s
por: Wang, Ping, et al.
Publicado: (2020)

Genetic analysis of the spindle checkpoint genes san-1, mdf-2, bub-3 and the CENP-F homologues hcp-1 and hcp-2 in Caenorhabditis elegans
por: Hajeri, Vinita A, et al.
Publicado: (2008)

5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
por: Andemariam, B., et al.
Publicado: (2023)

P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
por: Andemariam, B., et al.
Publicado: (2022)

Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience
por: Pellegrini, Mariangela, et al.
Publicado: (2023)

Acute Respiratory Infections (ARIs) Among Outpatient Healthcare Personnel (HCP)
por: Krosche, Amanda, et al.
Publicado: (2016)

Spectral Features of Canthaxanthin in HCP2. A QM/MM Approach
por: Clark, Kevin, et al.
Publicado: (2021)

Comparative Study on the Crystallography of Isothermal and Athermal Precipitations in HCP–BCC System
por: Liu, Hongwei
Publicado: (2022)

Epidemiology of sickle cell disease in Saudi Arabia
por: Jastaniah, Wasil
Publicado: (2011)

An HcpR paralog of Desulfovibrio gigas provides protection against nitrosative stress
por: da Silva, Sofia M., et al.
Publicado: (2015)

Structure and stability of hcp iron carbide precipitates: A first-principles study
por: Fang, C.M., et al.
Publicado: (2017)

An unconventional hydrogen effect that suppresses thermal formation of the hcp phase in fcc steels
por: Koyama, Motomichi, et al.
Publicado: (2018)

Size effects of lamellar twins on the strength and deformation mechanisms of nanocrystalline hcp cobalt
por: Wang, Wen, et al.
Publicado: (2017)

LncRNA HCP5 : A Potential Biomarker for Diagnosing Gastric Cancer
por: Qin, Shiyi, et al.
Publicado: (2021)

Grp94 Inhibitor HCP1 Inhibits Human Dermal Fibroblast Senescence
por: Cui, Xiaoling, et al.
Publicado: (2022)

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)
por: Silva-Pinto, Ana C., et al.
Publicado: (2019)

Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
por: Alashkar, Ferras, et al.
Publicado: (2022)

Quorum Sensing Regulation of the Two hcp Alleles in Vibrio cholerae O1 Strains
por: Ishikawa, Takahiko, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nnbc98hgsj5pnre4n256vku9ft